Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening

被引：0
|
作者：
Warner K. Huh
Erin Williams
Joice Huang
Tommy Bramley
Nick Poulios
机构：
[1] University of Alabama at Birmingham,
[2] Xcenda,undefined
[3] Roche Molecular Diagnostics,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Cervical Cancer; Cervical Intraepithelial Neoplasia; Cervical Cancer Screening; Cervical Screening; Cervical Cancer Incidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 107
页数：12
相关论文
共 50 条
  • [21] Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    E A Burger
    J D Ortendahl
    S Sy
    I S Kristiansen
    J J Kim
    British Journal of Cancer, 2012, 106 : 1571 - 1578
  • [22] 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
    Matejka Rebolj
    Adam R. Brentnall
    Christopher Mathews
    Karin Denton
    Miles Holbrook
    Tanya Levine
    Alexandra Sargent
    John Smith
    John Tidy
    Xenia Tyler
    Henry Kitchener
    British Journal of Cancer, 2019, 121 : 455 - 463
  • [23] Human papillomavirus testing and genotyping in cervical screening
    Rebolj, Matejka
    Lynge, Elsebeth
    Bonde, Jesper
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (07) : 1023 - 1031
  • [24] Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Goldhaber-Fiebert, Jeremy D.
    Stout, Natasha K.
    Salomon, Joshua A.
    Kuntz, Karen M.
    Goldie, Sue J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (05): : 308 - 320
  • [25] 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
    Reboilj, Matejka
    Brentnall, Adam R.
    Mathews, Christopher
    Denton, Karin
    Holbrook, Miles
    Levine, Tanya
    Sargent, Alexandra
    Smith, John
    Tidy, John
    Tyler, Xenia
    Kitchener, Henry
    Ellis, Kay
    Evans, Chris
    Frew, Viki
    Giles, Thomas
    Hunt, Katherine
    Moss, Sue
    Parker, Janet
    Patnick, Julietta
    Rimmer, Janet
    Smith, David
    Stubbs, Ruth
    Tidbury, Penelope
    BRITISH JOURNAL OF CANCER, 2019, 121 (06) : 455 - 463
  • [26] Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
    Ge, Shichao
    Gong, Bo
    Cai, Xushan
    Yang, Xiaoer
    Gan, Xiaowei
    Tong, Xinghai
    Li, Haichuan
    Zhu, Meijuan
    Yang, Fengyun
    Zhou, Hongrong
    Hong, Guofan
    CANCER MEDICINE, 2012, 1 (01): : 59 - 67
  • [27] Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
    Bhatla, Neerja
    Suri, Vanita
    Basu, Partha
    Shastri, Surendra
    Datta, Sanjoy K.
    Bi, Dan
    Descamps, Dominique J.
    Bock, Hans L.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (01) : 123 - 132
  • [28] Cost-effectiveness of a cervical screening program with human papillomavirus vaccine
    Sopina, Elizaveta
    Ashton, Toni
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 290 - 297
  • [29] COST-MINIMIZATION ANALYSIS OF HPV 16/18 GENOTYPING TEST VERSUS HPV REFLEX GENOTYPING FOR CERVICAL CANCER SCREENING
    Skroumpelos, A.
    Agorastos, T.
    Chatzistamatiou, K.
    Poulios, N.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2017, 20 (09) : A588 - A588
  • [30] Re: Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
    Giorgi Rossi, Paolo
    Zappa, Marco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (22): : 1654 - 1654
12345